Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03498378 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03498378
- Sponsor
- Kathryn Gold
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2020-02-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.